Hikal (NSE:HIKAL) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 02, 2026)


NSE:HIKAL Hikal Ltd NSE:HIKAL
67 GF Score
Price ₹218.96
GF Value ₹275.89
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hikal Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Hikal's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

NSE:HIKAL vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hikal's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hikal Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikal's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Hikal's Margin of Safety % (DCF FCF Based) falls into.


NSE:HIKAL
67GF Score
Hikal Ltd NSE:HIKAL
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hikal (NSE:HIKAL) Overvalued in 2026?

Based on GuruFocus' analysis, Hikal stock appears to be undervalued. The current stock price of ₹218.96 is trading 20.6% below its estimated GF Value™ of ₹275.89. GuruFocus considers Hikal to be Modestly Undervalued.

Key valuation signals for NSE:HIKAL:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹275.89 vs. price of ₹218.96 (20.6% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the NSE:HIKAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hikal Business Description

Other Exchanges 524735:India
Address Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai, MH, IND, 400 614
Hikal Ltd manufactures chemical intermediates, specialty chemicals, active pharmaceutical ingredients, and contract research activities. Its products are distributed to the pharmaceutical, biotech, agrochemical, and specialty chemical industries. Its segments include Crop Protection and Pharmaceuticals. The majority of the revenue is derived from the pharmaceutical segment.
67GF Score

Get the complete analysis for NSE:HIKAL

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹218.96
Price
₹275.89
GF Value